Cresco Labs (CSE: CL) announced on December 12th that the company has received the first approval of its kind to operate a medical cannabis dispensary in Ohio. The company’s dispensary is located in Wintersville and offers a range of pharmaceutical-grade medical cannabis products for eligible patients in the state that include transdermal patches, oral spays, pills, and more. The Wintersville dispensary offers, along with its premium-quality line of cannabis products, a comprehensive one-on-one consultation session for patients to discuss their symptoms and cannabis use in private.
Chief Executive Officer of Cresco Labs, Charles Bachtell, said: “Receiving the first approval to operate is a major milestone in the transformation of the cannabis program in Ohio. This is also a big step forward for Cresco along our path of unparalleled speed to market, powerful influence in industry development, and proven execution in consumer markets.”
The company also has a 50,000 sq. ft. cultivation facility within the vicinity of the Wintersville dispensary that will eventually supply dispensaries across Ohio with Cresco Labs branded cannabis products.
Learn more about exciting cannabis investment opportunities in the Cannin Report. Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll help you determine which cannabis companies to invest in.